remmy tirzepatide Tirzepatide | Personalized Weight Loss

Tirzepatide (trade name Mounjaro) is a new glucose-lowering medicine in the incretin family which, to date, has included the glucagon-like peptide-1 (GLP-1) receptor agonists (such as dulaglutide and semaglutide) and dipeptidyl peptidase-4 (DPP-4) inhibitors (including linagliptin and sitagliptin)

The dosing is gradually escalated over several weeks to minimize gastrointestinal side effects, starting at 2.5 mg weekly (a titration dose not intended for glycemic control) and potentially increasing to a maximum maintenance dose of 15 mg weekly, depending on the indication and individual patient response

Verified review - view original Easy to order, fast shipping, no subscription required

Should I skip my dose if I plan to drink

For many patients, this means more significant results in their weight loss journey